\-\ Texto\\:\\ \ \(0\)\
\-\ slender\\,\\ elderly\\ male\\.\\ \\ no\\ abdominal\\ pain\\,\\ no\\ localized\\ symptoms\\.\ \(0\)\
\-\ in\\ this\\ older\\ patient\\ with\\ multiple\\ comorbidities\\ and\\ surgical\\ risk\\ factors\\,\\ periodic\\ monitoring\\ is\\ currently\\ planned\\.\ \(0\)\
\-\ lobulated\\ multicystic\\ lesion\\ which\\ involves\\ the\\ pancreatic\\ head\\ and\\ uncinate\\ process\\,\\ predominantly\\.\\ \\ the\\ main\\ pancreatic\\ duct\\ is\\ dilated\\ to\\ 10mm\\ and\\ there\\ is\\ also\\ branch\\ duct\\ involvement\\ within\\ the\\ pancreatic\\ body\\.\\ \\ no\\ mural\\ nodules\\ or\\ solid\\ masses\\ are\\ identified\\.\ \(0\)\
\-\ combined\\-type\\ intraductal\\ papillary\\ mucinous\\ neoplasm\ \(0\)\
\-\ \\â\\€\\¢\\ chronic\\ pancreatitis\ \(0\)\
\-\ \\â\\€\\¢\\ pancreatic\\ pseudocyst\ \(1\)\
\-\ \\â\\€\\¢\\ mucinous\\ cystic\\ neoplasm\ \(0\)\
\-\ \\â\\€\\¢\\ serous\\ cystadenoma\ \(1\)\
\-\ 79\\ y\\/o\\ white\\ male\\,\\ preoperative\\ evaluation\\ pending\\ cabg\\.\\ \\ history\\ of\\ hypertension\\,\\ hyperlipidemia\\ and\\ diabetes\\.\\ \\ recent\\ 50\\ lb\\ weight\\ loss\\.\ \(0\)\
\-\ intraductal\\ papillary\\ mucinous\\ neoplasm\\ \\(ipmn\\)\\,\\ also\\ referred\\ to\\ in\\ previous\\ literature\\ as\\ intraductal\\ papillary\\ mucinous\\ tumor\\ \\(ipmt\\)\\ is\\ a\\ low\\-grade\\ malignancy\\ that\\ arises\\ from\\ the\\ epithelial\\ lining\\ of\\ the\\ main\\ or\\ branch\\ pancreatic\\ ducts\\,\\ and\\ is\\ characterized\\ by\\ excessive\\ mucin\\ production\\.\\ \\ ipmn\\ is\\ classified\\ into\\ three\\ types\\:\\ branch\\ pancreatic\\ duct\\ type\\,\\ main\\ pancreatic\\ duct\\ type\\,\\ and\\ combined\\ type\\.\\ \\ combined\\ type\\ is\\ the\\ most\\ common\\.\ \(0\)\
\-\ ipmn\\ presents\\ clinically\\ with\\ diarrhea\\,\\ pain\\,\\ weight\\ loss\\,\\ acute\\ pancreatitis\\ and\\ diabetes\\.\\ \\ typical\\ age\\ of\\ onset\\ is\\ 60\\-80\\ y\\/o\\,\\ more\\ commonly\\ in\\ males\\.\ \(0\)\
\-\ ct\\ findings\\ for\\ branch\\ pancreatic\\ duct\\ type\\ include\\ a\\ thin\\,\\ irregular\\ and\\ peripheral\\ lobulated\\ multicystic\\ lesion\\ \\(\\â\\€\\œgrape\\-like\\â\\€\\\\ clusters\\)\\.the\\ main\\ pancreatic\\ duct\\ type\\ appears\\ as\\ a\\ markedly\\ dilated\\ and\\ tortuous\\ main\\ pancreatic\\ duct\\.\\ \\ polypoid\\ lesions\\ may\\ be\\ seen\\ lining\\ the\\ main\\ duct\\.\\ \\ the\\ combined\\ type\\ appears\\ as\\ a\\ multicystic\\ lesion\\ \\(commonly\\ within\\ the\\ uncinate\\ process\\)\\ which\\ is\\ contiguous\\ with\\ a\\ markedly\\ dilated\\ and\\ tortuous\\ main\\ pancreatic\\ duct\\.\\ mrcp\\ will\\ show\\ communication\\ between\\ the\\ dilated\\ duct\\ and\\ cystic\\ lesions\\.\ \(0\)\
\-\ the\\ differential\\ diagnosis\\ for\\ ipmn\\ includes\\ chronic\\ pancreatitis\\,\\ pancreatic\\ pseudocyst\\,\\ mucinous\\ cystic\\ neoplasm\\ and\\ serous\\ cystadenoma\\.\\ \\ this\\ patient\\ had\\ no\\ history\\ of\\ pancreatitis\\.\\ \\ \ \(0\)\
\-\ imaging\\ features\\ of\\ ipmn\\ with\\ invasive\\ carcinoma\\ may\\ include\\ mural\\ nodularity\\ or\\ solid\\ mass\\ measuring\\ 3\\-10\\ mm\\,\\ diffuse\\ or\\ multifocal\\ main\\ duct\\ involvement\\,\\ main\\ or\\ combined\\ duct\\ types\\,\\ main\\ pancreatic\\ duct\\ measuring\\ \\>\\ 10\\-15\\ mm\\,\\ branch\\ duct\\ type\\ measuring\\ \\>\\ 3\\ cm\\ or\\ mural\\ nodularity\\,\\ common\\ bile\\ duct\\ \\>\\ 15\\ mm\\,\\ or\\ evidence\\ of\\ metastases\\.\\ \\ generally\\,\\ main\\ duct\\ and\\ combined\\ duct\\ types\\ are\\ resected\\ in\\ good\\ surgical\\ candidates\\.\\ \\ branch\\ duct\\ type\\ ipmn\\ without\\ suggestion\\ of\\ invasive\\ carcinoma\\ may\\ be\\ monitored\\.\\ \\ although\\ all\\ ipmns\\ are\\ felt\\ to\\ have\\ malignant\\ potential\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ lim\\ jh\\,\\ et\\ al\\.\\ radiologic\\ spectrum\\ of\\ intraductal\\ papillary\\ mucinous\\ tumor\\ of\\ the\\ pancreas\\.\\ radiographics\\.\\ 2001\\.\\ 21\\(2\\)\\:323\\-40\\.\ \(0\)\
\-\ prasad\\ sr\\,\\ et\\ al\\.\\ intraductal\\ papillary\\ tumors\\ of\\ the\\ pancreas\\.\\ abdom\\ imaging\\.\\ 2003\\.\\ 28\\(3\\)\\:357\\-65\\.\ \(0\)\
\-\ taouli\\ b\\,\\ et\\ al\\.\\ \\ intraductal\\ papillary\\ mucinous\\ tumors\\ of\\ the\\ pancreas\\:\\ features\\ with\\ multimodality\\ imaging\\.\\ j\\ comput\\ assist\\ tomogr\\.\\ 2002\\.\\ 26\\(2\\)\\:223\\-31\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ duct\\:\\ 0\\.45816638930322007\ \(0\)\
\-\ pancreatic\\:\\ 0\\.3484782020060905\ \(0\)\
\-\ main\\:\\ 0\\.28347379164591263\ \(0\)\
\-\ ipmn\\:\\ 0\\.2552286548630609\ \(0\)\
\-\ mucinous\\:\\ 0\\.22141729522738365\ \(0\)\
\-\ intraductal\\:\\ 0\\.20644184486858097\ \(0\)\
\-\ type\\:\\ 0\\.1983625049272557\ \(0\)\
\-\ combined\\:\\ 0\\.17593626994916406\ \(0\)\
\-\ branch\\:\\ 0\\.1740507338712954\ \(0\)\
\-\ papillary\\:\\ 0\\.16533283259356127\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.11729084663277603\ \(0\)\
\-\ multicystic\\:\\ 0\\.10605618855891139\ \(0\)\
\-\ mural\\:\\ 0\\.09061021960846927\ \(0\)\
\-\ the\\:\\ 0\\.08850235041573522\ \(0\)\
\-\ dilated\\:\\ 0\\.08471238060685304\ \(0\)\
\-\ pancreas\\:\\ 0\\.08337339758539665\ \(0\)\
\-\ types\\:\\ 0\\.08249458128849446\ \(0\)\
\-\ neoplasm\\:\\ 0\\.08074215787374157\ \(0\)\
\-\ uncinate\\:\\ 0\\.0802035621890071\ \(0\)\
\-\ and\\:\\ 0\\.07943187320486197\ \(0\)\
\-\ is\\:\\ 0\\.07287990570869374\ \(0\)\
\-\ or\\:\\ 0\\.07200655158486145\ \(0\)\
\-\ al\\:\\ 0\\.07048392578336952\ \(0\)\
\-\ et\\:\\ 0\\.06949016350877651\ \(0\)\
\-\ measuring\\:\\ 0\\.0686260017535787\ \(0\)\
\-\ lining\\:\\ 0\\.06839073551374777\ \(0\)\
\-\ serous\\:\\ 0\\.06798412365960613\ \(0\)\
\-\ pseudocyst\\:\\ 0\\.06721582605506395\ \(0\)\
\-\ tortuous\\:\\ 0\\.06551245141050865\ \(0\)\
\-\ nodularity\\:\\ 0\\.06551245141050865\ \(0\)\
\-\ of\\:\\ 0\\.06365249934853431\ \(0\)\
\-\ mm\\:\\ 0\\.06348387727479086\ \(0\)\
\-\ cystadenoma\\:\\ 0\\.05984628341026732\ \(0\)\
\-\ lobulated\\:\\ 0\\.054550414535808216\ \(0\)\
\-\ diabetes\\:\\ 0\\.05401864293200172\ \(0\)\
\-\ invasive\\:\\ 0\\.05381334368182472\ \(0\)\
\-\ cystic\\:\\ 0\\.05342584009712595\ \(0\)\
\-\ markedly\\:\\ 0\\.052215221447361675\ \(0\)\
\-\ features\\:\\ 0\\.04758495685076061\ \(0\)\
\-\ ipmns\\:\\ 0\\.04728782738537657\ \(0\)\
\-\ abdom\\:\\ 0\\.04728782738537657\ \(0\)\
\-\ taouli\\:\\ 0\\.04728782738537657\ \(0\)\
\-\ comput\\:\\ 0\\.04728782738537657\ \(0\)\
\-\ tomogr\\:\\ 0\\.04728782738537657\ \(0\)\
\-\ imaging\\:\\ 0\\.04661908183623122\ \(0\)\
\-\ solid\\:\\ 0\\.04533866898569247\ \(0\)\
\-\ slender\\:\\ 0\\.04518604358107304\ \(0\)\
\-\ prasad\\:\\ 0\\.04518604358107304\ \(0\)\
\-\ may\\:\\ 0\\.04464068740806639\ \(0\)\
\-\ process\\:\\ 0\\.044354643099292906\ \(0\)\
\-\ commonly\\:\\ 0\\.043759798889254915\ \(0\)\
\-\ ipmt\\:\\ 0\\.04369480423994006\ \(0\)\
\-\ multimodality\\:\\ 0\\.04369480423994006\ \(0\)\
\-\ tumors\\:\\ 0\\.04349346896454219\ \(0\)\
\-\ appears\\:\\ 0\\.04330733697482267\ \(0\)\
\-\ involvement\\:\\ 0\\.042803273022290325\ \(0\)\
\-\ lim\\:\\ 0\\.04253810914384349\ \(0\)\
\-\ lesion\\:\\ 0\\.04252861205926936\ \(0\)\
\-\ weight\\:\\ 0\\.041240353787177636\ \(0\)\
\-\ sr\\:\\ 0\\.04010178109450355\ \(0\)\
\-\ 15\\:\\ 0\\.039962329280196066\ \(0\)\
\-\ comorbidities\\:\\ 0\\.03894508599840697\ \(0\)\
\-\ no\\:\\ 0\\.03846246420196014\ \(0\)\
\-\ clusters\\:\\ 0\\.03845103265499438\ \(0\)\
\-\ candidates\\:\\ 0\\.03799999729020001\ \(0\)\
\-\ mrcp\\:\\ 0\\.036843302194103436\ \(0\)\
\-\ jh\\:\\ 0\\.036843302194103436\ \(0\)\
\-\ mucin\\:\\ 0\\.036508757949067036\ \(0\)\
\-\ 10mm\\:\\ 0\\.036194501936088926\ \(0\)\
\-\ loss\\:\\ 0\\.03602946303888959\ \(0\)\
\-\ as\\:\\ 0\\.03563717156727611\ \(0\)\
\-\ lb\\:\\ 0\\.03561794865487371\ \(0\)\
\-\ carcinoma\\:\\ 0\\.035374096951015406\ \(0\)\
\-\ assist\\:\\ 0\\.03535206285297046\ \(0\)\
\-\ include\\:\\ 0\\.03518698767726174\ \(0\)\
\-\ chronic\\:\\ 0\\.035103041685428486\ \(0\)\
\-\ polypoid\\:\\ 0\\.034858009509557863\ \(0\)\
\-\ cabg\\:\\ 0\\.03462758772288418\ \(0\)\
\-\ classified\\:\\ 0\\.033992061829803064\ \(0\)\
\-\ lesions\\:\\ 0\\.03396402588065133\ \(0\)\
\-\ are\\:\\ 0\\.033660670178992706\ \(0\)\
\-\ common\\:\\ 0\\.0335384163245245\ \(0\)\
\-\ periodic\\:\\ 0\\.033250279048666925\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.0324512179314354\ \(0\)\
\-\ preoperative\\:\\ 0\\.03216316401303613\ \(0\)\
\-\ excessive\\:\\ 0\\.03189027802549953\ \(0\)\
\-\ suggestion\\:\\ 0\\.03189027802549953\ \(0\)\
\-\ epithelial\\:\\ 0\\.031759039707533944\ \(0\)\
\-\ production\\:\\ 0\\.031759039707533944\ \(0\)\
\-\ monitored\\:\\ 0\\.031759039707533944\ \(0\)\
\-\ arises\\:\\ 0\\.031631042175340525\ \(0\)\
\-\ 79\\:\\ 0\\.03126498636412135\ \(0\)\
\-\ elderly\\:\\ 0\\.031148495244363382\ \(0\)\
\-\ communication\\:\\ 0\\.031034564577447663\ \(0\)\
\-\ tumor\\:\\ 0\\.030932970950380473\ \(0\)\
\-\ ducts\\:\\ 0\\.030499694986348875\ \(0\)\
\-\ males\\:\\ 0\\.030499694986348875\ \(0\)\
\-\ contiguous\\:\\ 0\\.030499694986348875\ \(0\)\
\-\ planned\\:\\ 0\\.030300299762348278\ \(0\)\
\-\ spectrum\\:\\ 0\\.03001488988209546\ \(0\)\
\-\ radiographics\\:\\ 0\\.0298329892297925\ \(0\)\
\-\ monitoring\\:\\ 0\\.029487285375120357\ \(0\)\
\-\ in\\:\\ 0\\.029423578201392454\ \(0\)\
\-\ with\\:\\ 0\\.028950241682603416\ \(0\)\
\-\ literature\\:\\ 0\\.028858194785998884\ \(0\)\
\-\ surgical\\:\\ 0\\.02874333698283515\ \(0\)\
\-\ multifocal\\:\\ 0\\.02871216719502345\ \(0\)\
\-\ bile\\:\\ 0\\.02871216719502345\ \(0\)\
\-\ 2002\\:\\ 0\\.028297254880063016\ \(0\)\
\-\ diarrhea\\:\\ 0\\.02797518630091316\ \(0\)\
\-\ 2001\\:\\ 0\\.02791310607779192\ \(0\)\
\-\ also\\:\\ 0\\.027817149293612498\ \(0\)\
\-\ radiologic\\:\\ 0\\.027555472098926875\ \(0\)\
\-\ older\\:\\ 0\\.02744154143201115\ \(0\)\
\-\ within\\:\\ 0\\.02723746128813557\ \(0\)\
\-\ characterized\\:\\ 0\\.027167210930971058\ \(0\)\
\-\ resected\\:\\ 0\\.027061418755514276\ \(0\)\
\-\ which\\:\\ 0\\.026890954990518336\ \(0\)\
\-\ 2003\\:\\ 0\\.026610383390719913\ \(0\)\
\-\ localized\\:\\ 0\\.02656260759930899\ \(0\)\
\-\ potential\\:\\ 0\\.026421866736658944\ \(0\)\
\-\ male\\:\\ 0\\.026330823908790327\ \(0\)\
\-\ felt\\:\\ 0\\.025978550862008603\ \(0\)\
\-\ predominantly\\:\\ 0\\.025894262229683843\ \(0\)\
\-\ involves\\:\\ 0\\.0257296885127575\ \(0\)\
\-\ generally\\:\\ 0\\.025047644479129317\ \(0\)\
\-\ factors\\:\\ 0\\.025012261156256856\ \(0\)\
\-\ clinically\\:\\ 0\\.02457299341666092\ \(0\)\
\-\ 28\\:\\ 0\\.02454069651047608\ \(0\)\
\-\ pending\\:\\ 0\\.024320082932355404\ \(0\)\
\-\ good\\:\\ 0\\.02404957094837471\ \(0\)\
\-\ 26\\:\\ 0\\.0240203672842373\ \(0\)\
\-\ be\\:\\ 0\\.02399020608416611\ \(0\)\
\-\ metastases\\:\\ 0\\.023905170617394972\ \(0\)\
\-\ 21\\:\\ 0\\.023627904708453957\ \(0\)\
\-\ references\\:\\ 0\\.023574187785534544\ \(0\)\
\-\ nodules\\:\\ 0\\.02349464192778984\ \(0\)\
\-\ thin\\:\\ 0\\.0230173602452834\ \(0\)\
\-\ includes\\:\\ 0\\.02299341730814878\ \(0\)\
\-\ typical\\:\\ 0\\.02285203663516605\ \(0\)\
\-\ irregular\\:\\ 0\\.02282884359122243\ \(0\)\
\-\ currently\\:\\ 0\\.022714409878387177\ \(0\)\
\-\ hypertension\\:\\ 0\\.02262464769304912\ \(0\)\
\-\ history\\:\\ 0\\.022594406728637\ \(0\)\
\-\ previous\\:\\ 0\\.02234321208016396\ \(0\)\
\-\ to\\:\\ 0\\.022176838001759187\ \(0\)\
\-\ malignancy\\:\\ 0\\.022136665367320986\ \(0\)\
\-\ referred\\:\\ 0\\.021879899444627458\ \(0\)\
\-\ pain\\:\\ 0\\.021162003004263106\ \(0\)\
\-\ peripheral\\:\\ 0\\.021144543988150754\ \(0\)\
\-\ risk\\:\\ 0\\.021127849491679694\ \(0\)\
\-\ malignant\\:\\ 0\\.021078086197427525\ \(0\)\
\-\ identified\\:\\ 0\\.020963796664737574\ \(0\)\
\-\ 50\\:\\ 0\\.02065049064473816\ \(0\)\
\-\ this\\:\\ 0\\.020321122092638776\ \(0\)\
\-\ masses\\:\\ 0\\.020130246819655508\ \(0\)\
\-\ although\\:\\ 0\\.020130246819655508\ \(0\)\
\-\ recent\\:\\ 0\\.020021400055616687\ \(0\)\
\-\ three\\:\\ 0\\.019849258370752916\ \(0\)\
\-\ white\\:\\ 0\\.019509019162149723\ \(0\)\
\-\ body\\:\\ 0\\.019460460149680815\ \(0\)\
\-\ patient\\:\\ 0\\.019234850064146238\ \(0\)\
\-\ between\\:\\ 0\\.01921273071195727\ \(0\)\
\-\ differential\\:\\ 0\\.01921273071195727\ \(0\)\
\-\ will\\:\\ 0\\.019031624547612605\ \(0\)\
\-\ onset\\:\\ 0\\.018987319690945602\ \(0\)\
\-\ show\\:\\ 0\\.018771303573590793\ \(0\)\
\-\ age\\:\\ 0\\.01856393045394276\ \(0\)\
\-\ diffuse\\:\\ 0\\.018543642221884468\ \(0\)\
\-\ evaluation\\:\\ 0\\.018033048275866534\ \(0\)\
\-\ for\\:\\ 0\\.017924485898185627\ \(0\)\
\-\ head\\:\\ 0\\.017635809475039\ \(0\)\
\-\ all\\:\\ 0\\.017601929376169813\ \(0\)\
\-\ cm\\:\\ 0\\.016982012940325666\ \(0\)\
\-\ evidence\\:\\ 0\\.016783607162281205\ \(0\)\
\-\ more\\:\\ 0\\.01623673562862755\ \(0\)\
\-\ symptoms\\:\\ 0\\.016178673129765182\ \(0\)\
\-\ abdominal\\:\\ 0\\.016172261704490532\ \(0\)\
\-\ acute\\:\\ 0\\.01599588767133672\ \(0\)\
\-\ into\\:\\ 0\\.015718557251189782\ \(0\)\
\-\ without\\:\\ 0\\.015596720226526596\ \(0\)\
\-\ most\\:\\ 0\\.01538878496957918\ \(0\)\
\-\ diagnosis\\:\\ 0\\.015328541287371296\ \(0\)\
\-\ have\\:\\ 0\\.014771512084505651\ \(0\)\
\-\ had\\:\\ 0\\.014732537189060741\ \(0\)\
\-\ findings\\:\\ 0\\.014593660094220846\ \(0\)\
\-\ multiple\\:\\ 0\\.014463012470424185\ \(0\)\
\-\ presents\\:\\ 0\\.014224383499180978\ \(0\)\
\-\ seen\\:\\ 0\\.013921010406486087\ \(0\)\
\-\ that\\:\\ 0\\.012831988859287156\ \(0\)\
\-\ by\\:\\ 0\\.012556860814330773\ \(0\)\
\-\ there\\:\\ 0\\.01176555246531108\ \(0\)\
\-\ from\\:\\ 0\\.01174369207793661\ \(0\)\
\-\ mass\\:\\ 0\\.011294702212678311\ \(0\)\
\-\ ct\\:\\ 0\\.011257329039439375\ \(0\)\
